Clinical studies recruiting near Nedlands

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · Sir Charles Gairdner Hospital · Pfizer · NCT07028853 The Safety and Tolerability of LBS-007 in Patients With Relapsed or Resistant Acute Leukaemias
Phase 1/Phase 2 · Hollywood Private Hospital · Lin BioScience, Inc · NCT05756322 Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma Wi
Phase 3 · Research Site · AstraZeneca · NCT07509151 Tissue Repair Gel in Venous Leg Ulcers in AU/US
Phase 3 · Clincial Research Site 75 · TR Therapeutics · NCT06707103 Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma (TRIgnite-1)
Phase 1 · Linear Clinical Research · Ichnos Sciences SA · NCT05862012 A Study to Assess Adverse Events and Change in Disease Activity in Participants With Platinum-Resistant Advanced High-Gr
Phase 2 · Sir Charles Gairdner Hospital /ID# 272116 · AbbVie · NCT06682988 An Open Label Dose Finding Study of PTT-4256 in Patients With Solid Tumours (RAISIC-1).
Phase 1/Phase 2 · Linear Clinical Research · Pathios Therapeutics Pty Ltd · NCT06634849 Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
Phase 3 · Perth Children's Hospital · PedAL BCU, LLC · NCT05183035 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Linear Clinical Research Limited · Amgen · NCT07037433 Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Ag
Phase 1 · Sir Charles Gairdner Hospital /ID# 265985 · AbbVie · NCT06896916 Feasibility of the InnoVein Valve and Delivery System for Chronic Venous Insufficiency
NA · Hollywood Private Hospital · InnoVein · NCT04253301 Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid Tumors
Phase 1/Phase 2 · Linear Clinical Research Limited · Impact Therapeutics, Inc. · NCT05269316 Quality of Pediatric Resuscitation in a Multicenter Collaborative
Phase N/A · Perth Children's Hospital · Children's Hospital of Philadelphia · NCT02708134 A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-159642 in Participants With Advanced Solid T
Phase 1 · Linear Clinical · Vividion Therapeutics, Inc. · NCT06804824 Combination Therapy for the Treatment of Diffuse Midline Gliomas
Phase 2 · Perth Children's Hospital · University of California, San Francisco · NCT05009992 A Clinical Study of MK-4716 in People With Certain Solid Tumors (MK-4716-001)
Phase 1 · One Clinical Research ( Site 0454) · Merck Sharp & Dohme LLC · NCT07247110 A Study of Terbium 161 (161Tb)-RAD402 in Participants With CRPC
Phase 1/Phase 2 · Icon Cancer Centre Hollywood · Radiopharm Theranostics, Ltd · NCT07259213 Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced S
Phase 1/Phase 2 · One Clinical Research · ModernaTX, Inc. · NCT05533697 A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymph
Phase 3 · One Clinical Research · Loxo Oncology, Inc. · NCT05254743 ROADMAP Clinical Trial
Phase 4 · Sir Charles Gairdner Hospital · University of Newcastle, Australia · NCT06771050 A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants Wit
Phase 3 · One Clinical Research ( Site 0200) · Merck Sharp & Dohme LLC · NCT06077760 A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone
Phase 3 · Local Institution - 0040 · Celgene · NCT05519085 Study of XmAb412 in Healthy Participants
Phase 1 · Xencor Investigative Site · Xencor, Inc. · NCT07713485 SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
Phase 2 · Government of Western Australia - Child and Adolescent Healt · SAb Biotherapeutics, Inc. · NCT07187531 A Study of Intravenous CPTX2309 in Healthy Participants and Participants With Moderate to Severe Rheumatoid Arthritis (R
Phase 1 · Linear Clinical Research · Capstan Therapeutics · NCT06917742 A Phase I/II, Dose-finding Study to Assess the Safety, Reactogenicity, and Immunogenicity of a Broadly Protective Sarbec
Phase 1/Phase 2 · Linear · SK Bioscience Co., Ltd. · NCT07280858 IKS014 in Advanced Solid Tumors That Express HER2
Phase 1 · Linear Clinical Research · Iksuda Therapeutics Ltd. · NCT05872295 Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic
Phase 2 · Research Site · AstraZeneca · NCT06535607 A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung C
Phase 3 · One Clinical Research ( Site 2103) · Merck Sharp & Dohme LLC · NCT06623422 A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alon
Phase 1/Phase 2 · One Clinical Research Pty Ltd · BioNTech SE · NCT07070232

Look up another city

Look up another condition